Loading...
Improved cancer treatment has led to an increasingly large population of survivors, and survivorship might affect future cardiovascular (CV) risk through the effects of the cancers themselves, cardiotoxic treatment modalities, or shared risk factors (e.g., smoking). Using public health databases, British researchers assembled a cohort of more than 100,000 survivors of the 20 most common adult cancers, matched them to more than 500,000 cancer-free controls, and recorded adverse CV outcomes during as long as 16 years of follow-up.
After adjustment for shared risk factors, survivors had significantly higher risk than controls for the following outcomes: venous thromboembolism (VTE) in survivors of 18 cancers, heart failure or cardiomyopathy in …